(Q34114550)

31 July 2017

1 reference

title

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival (English)

1 reference

autoimmune lymphoproliferative syndrome

31 July 2017

main subject

0 references

author name string

Bleesing JJ

series ordinal

1

1 reference

31 July 2017

Straus SE

series ordinal

2

1 reference

31 July 2017

Fleisher TA

series ordinal

3

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Pediatric Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1291-1310

1 reference

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Dyserythropoiesis associated with a Fas-deficient condition in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Faces and phases of human CD8 T-cell development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Phenotypical and Functional Characterization of Double-Negative (CD4-CD8-) alphabeta T-Cell Receptor Positive Cells from an Immunodeficient Patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Chronic pseudomalignant immuneproliferation (Canale-Smith syndrome) (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Lymphadenopathy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Clinical, immunological, and pathological consequences of Fas-deficient conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Pathological findings in human autoimmune lymphoproliferative syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Fas gene mutation in the progression of adult T cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Chronic lymphoproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

The role of Fas and related death receptors in autoimmune and other disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

CD5 B cells in autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

Chronic lymphadenopathy simulating malignant lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970272-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70272-8

1 reference

31 July 2017

1 reference